Geistlich Pharma AG
Geistlich Pharma AG, a leading name in the regenerative medicine sector, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 1851, the company has established itself as a pioneer in dental and orthopaedic biomaterials, focusing on innovative solutions for tissue regeneration. With a strong emphasis on research and development, Geistlich Pharma offers a range of unique products, including collagen-based membranes and bone substitutes, which are renowned for their quality and efficacy. The company’s commitment to scientific excellence has positioned it as a trusted partner in the healthcare industry, achieving notable milestones in clinical applications and product advancements. Geistlich Pharma AG continues to set benchmarks in regenerative medicine, enhancing patient outcomes worldwide.
DitchCarbon Score
How does Geistlich Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Geistlich Pharma AG's score of 26 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Geistlich Pharma AG's reported carbon emissions
Geistlich Pharma AG, headquartered in Switzerland (CH), currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or climate pledges. In the absence of specific emissions data or commitments, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This includes setting science-based targets and engaging in initiatives aimed at reducing their carbon footprint. However, without concrete data or commitments from Geistlich Pharma AG, it is unclear how they align with these industry trends. As the company continues to navigate its environmental responsibilities, stakeholders may look for future disclosures regarding emissions and climate strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Geistlich Pharma AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
